Dow Down0.22% Nasdaq Up0.14%

Quintiles Transnational Holdings Inc. (Q)

-NYSE
55.74 Down 0.60(1.06%) Aug 22, 4:03PM EDT
ProfileGet Profile for:
Quintiles Transnational Holdings Inc.
4820 Emperor Boulevard
Durham, NC 27703
United States - Map
Phone: 919-998-2000
Website: http://www.quintiles.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Medical Laboratories & Research
Full Time Employees:30,700

Business Summary 

Quintiles Transnational Holdings Inc., through its subsidiary, Quintiles Transnational Corp., provides biopharmaceutical development services and commercial outsourcing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through two segments, Product Development and Integrated Healthcare Services. The Product Development segment provides project management and clinical monitoring services, including study design and operational planning, investigator/site recruitment, site and regulatory start up, patient recruitment, clinical monitoring, and project management for conducting various multi-site trials; and clinical trial support services comprising clinical data management, biostatistical, central laboratories, genomic laboratory, bioanalytical laboratories, cardiac safety and ECG, safety and pharmacovigilance, and phase I clinical pharmacology services. It also provides strategic planning and design services; and consulting services, such as product development strategy, regulatory and compliance, and process and IT implementation consulting services. The Integrated Healthcare Services segment offers commercial services comprising contract sales, market entry/market exit, integrated channel management, patient engagement, market access and commercialization consulting, and medical education services; communication and health engagement services, including digital patient, and brand and scientific communications services; and outcome-based services, such as observational studies, comparative effectiveness studies, and product and disease registry services. The company serves biopharmaceutical companies, including medical device and diagnostics companies. Quintiles Transnational Holdings Inc. was founded in 1982 and is based in Durham, North Carolina.

Key Statistics


Company Websites 
Home Page
Investor Relations
Employment
Search Yahoo! for:
More on Quintiles Transnational Holdings Inc.

Corporate Governance 
Quintiles Transnational Holdings Inc.’s ISS Governance QuickScore as of Aug 1, 2014 is 10. The pillar scores are Audit: 1; Board: 10; Shareholder Rights: 7; Compensation: 9.
Brought to you by Institutional Shareholder Services (ISS)

Key Executives 
 PayExercised
Mr. Dennis B. Gillings Ph.D., CBE, 70
Exec. Chairman
1.93M0.00
Mr. Thomas H. Pike , 55
Chief Exec. Officer and Director
2.58M0.00
Mr. Kevin K. Gordon , 51
Chief Financial Officer and Exec. VP
1.82M0.00
Mr. Michael I. Mortimer , 54
Consultant
1.86M0.00
Mr. Charles E. Williams ,
Principal Accounting Officer, Sr. VP and Corp. Controller
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders